Discovery channel feed – Endpoints News

Discovery channel feed

MIT lab creates tool to find cancer mutation drivers 'anywhere in the genome'

3 years ago

'Vaccines alone are insufficient': Merck, Aligos work with academic experts to find Covid antivirals as part of $65M NIH grant

3 years ago

Scientists are finally learning how to design proteins from scratch. Drug development may never be the same

3 years ago

Stanford study suggests brain fluid transfer from young to old mice can improve memory

3 years ago

Illumina and Deerfield link arms to drive 'genomics-first' drug discovery

4 years ago

Still-in-stealth biotech partners with Sloan Kettering scientists to make personalized cancer therapy more ‘public’

4 years ago

Can this tick biologist and her team of ‘weirdo science’ enthusiasts change the future of scientific research?

4 years ago

Axolotls, chemical cocktails, and a new route for stem cell therapy — maybe

4 years ago

New T cell immune response discovery points to 'out-of-box' cancer therapy options

4 years ago

A potential target for Alzheimer's treatment? Researchers unearth new immune response pathway

4 years ago

‘A major step forward': Scientists unveil new approach for designing protein drugs against any target

4 years ago

Can Moderna actually make a vaccine for the common cold? (And should it?)

4 years ago

Novo Nordisk, Gates Foundation pledge $90M to fund antiviral research for the next pandemic

4 years ago

Lululemon founder commits $100M to cure his rare disease

4 years ago

In new research paper, Novartis outlines how an old SMA program could alter the course of Huntington's

4 years ago

Amgen quietly kills an obesity program, casting bleak future for once-promising target

4 years ago

Two Pandion vets jump back into the startup world, this time using machine learning to build better immunology drugs

4 years ago

A faster 'protein printer' out of the UK earns new round of funding with plans to expand platform

4 years ago

Carl June: ‘We can now conclude that CAR-T cells can actually cure patients’

4 years ago

In historic first, surgeons transplant a genetically modified pig heart into a dying patient

4 years ago

Inside the multibillion-dollar, Silicon Valley-backed effort to reimagine how the world funds (and conducts) science

4 years ago

Will ‘original antigenic sin’ undermine Omicron boosters? New research suggests ‘no’

4 years ago

Researchers move closer to deciphering blood clots from AstraZeneca, J&J's Covid-19 vaccines

4 years ago

GlaxoSmithKline, Oxford unveil new partnership pitting buzzy R&D advances against neurological disease

4 years ago

First page Previous page 1 234 5 6 Next page Last page